EUVIMEDEUVIMED entdecken
Crossref

Alternate-Day Recombinant FSH Dosing Is Non-Inferior to Daily Dosing for Controlled Ovarian Stimulation in Women with Normal Ovarian Reserve Undergoing IVF/ICSI

Shashank Sangoudar MS*

International Journal of Reproductive Research · 20.07.2026 · 5 (2)

DOI: 10.58489/2836-2225/036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Reproductive Research, online erschienen am 20.07.2026. Verfasst von Shashank Sangoudar MS*.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Daily recombinant FSH (rFSH) administration remains the standard for controlled ovarian stimulation in IVF/ICSI, yet it increases treatment burden, cost, and discomfort for patients. Evidence supporting reduced frequency dosing, particularly among women with normal ovarian reserve, is limited. This pilot randomized controlled trial evaluated the feasibility of an alternate day rFSH protocol after an initial five day daily phase. Sixty women were randomized to either continued daily rFSH or alternate day dosing once a leading follicle reached ≥14 mm. Baseline characteristics and ovarian reserve mark-ers were comparable across groups. The alternate day protocol significantly reduced total gonadotropin use and resulted in lower trigger day progesterone, while maintaining similar oocyte yield, MII oocyte rates, and embryological outcomes. Trends toward higher estradiol levels and more embryos were observed in the alternate day arm. These findings suggest that alternate day rFSH dosing is a feasible, patient friendly, and potentially cost saving strategy without compromising stimulation or laboratory outcomes. Larger studies are needed to validate its clinical utility.

Zitieren

APA

MS*, S. S. (2026). Alternate-Day Recombinant FSH Dosing Is Non-Inferior to Daily Dosing for Controlled Ovarian Stimulation in Women with Normal Ovarian Reserve Undergoing IVF/ICSI. International Journal of Reproductive Research, 5(2). https://doi.org/10.58489/2836-2225/036

Vancouver

MS* SS. Alternate-Day Recombinant FSH Dosing Is Non-Inferior to Daily Dosing for Controlled Ovarian Stimulation in Women with Normal Ovarian Reserve Undergoing IVF/ICSI. International Journal of Reproductive Research. 2026;5(2). doi:10.58489/2836-2225/036

BibTeX
@article{MS2026,
  author = {MS*, Shashank Sangoudar},
  title = {Alternate-Day Recombinant FSH Dosing Is Non-Inferior to Daily Dosing for Controlled Ovarian Stimulation in Women with Normal Ovarian Reserve Undergoing IVF/ICSI},
  journal = {International Journal of Reproductive Research},
  year = {2026},
  volume = {5},
  number = {2},
  doi = {10.58489/2836-2225/036}
}
Kostenlos starten →